ROXRO Pharma

Home | Site map | Search

About ROXRO
- Overview
  - Milestones
- Management
- Board of Directors
- Scientific Advisors
- Investors
Product Candidates
- Pipeline
  - 888 / Acute Pain
  - 828 / Migraine
- Nasal Delivery of Pain Drugs
Business Development
News & Media
- Press Releases
- Publications
- Upcoming Events, Presentations
Contact Us
- Directions

Full Speed to Recovery

You need to upgrade your Flash Player

A PHARMACEUTICAL COMPANY
focused on the treatment of pain

ROXRO PHARMA, Inc. is a privately-owned and virtually-organized specialty pharmaceutical company focused on the treatment of pain.

May 05, 2008

ROXRO PHARMA’s Phase 3 Intranasal Analgesic Data Receives Excellence
Award

April 28, 2008

ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment

April 16, 2008

ROXRO PHARMA Marks 5^th Year of Café Scientifique Sponsorship

ROXRO is developing two products for the treatment of acute pain:

ROX-888 The Efficacy of
Hospital-Strength Ketorolac
in a Convenient Form

ROX-828 Rapid-Onset Non-Opioid, Non-Triptan Migraine Treatment